LAS VEGAS, April 29, 2014 /PRNewswire/ -- GrowBLOX Sciences, Inc. (OTCQB: GBLX) began trading under the ticker symbol 'GBLX' on the OTC Markets as of the opening of the market yesterday, April 28, 2014. The new ticker reflects the Company name change from Signature Exploration and Production Corp.
For more information on GrowBLOX Sciences Inc., please visit http://www.gbsciences.com.
About GrowBLOX Sciences, Inc.
GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed a proprietary indoor growing chamber specifically designed for medical cannabis cultivation. The GrowBLOX chambers allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions. http://www.gbsciences.com
Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
CEO, GrowBLOX Sciences, Inc.
+1-844-843-BLOX ext. 01
SOURCE GrowBLOX Sciences, Inc.